Mingqian Feng

ORCID: 0000-0002-0654-8224
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Research and Treatments
  • Glycosylation and Glycoproteins Research
  • CAR-T cell therapy research
  • Toxin Mechanisms and Immunotoxins
  • Immune Cell Function and Interaction
  • Cancer Cells and Metastasis
  • Microbial Inactivation Methods
  • Bacteriophages and microbial interactions
  • Galectins and Cancer Biology
  • Metal complexes synthesis and properties
  • Immune cells in cancer
  • Liver physiology and pathology
  • Single-cell and spatial transcriptomics
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Microfluidic and Bio-sensing Technologies
  • Cancer-related molecular mechanisms research
  • Virus-based gene therapy research
  • Magnetism in coordination complexes
  • Wnt/β-catenin signaling in development and cancer
  • Immunotherapy and Immune Responses
  • Transgenic Plants and Applications
  • Metal-Catalyzed Oxygenation Mechanisms
  • Synthesis and biological activity

Huazhong Agricultural University
2019-2025

Hubei Provincial Center for Disease Control and Prevention
2024

National Institutes of Health
2010-2023

Center for Cancer Research
2010-2023

National Cancer Institute
2010-2023

MRC Laboratory of Molecular Biology
2011-2013

Cancer Genetics (United States)
2013

East China Normal University
2013

Human Computer Interaction (Switzerland)
2013

Frederick National Laboratory for Cancer Research
2013

Glypican-3 (GPC3) has emerged as a candidate therapeutic target in hepatocellular carcinoma (HCC), but the oncogenic role of GPC3 HCC is poorly understood. Here, we report human heavy-chain variable domain antibody, HN3, with high affinity ( K d = 0.6 nM) for cell-surface–associated molecules. The antibody recognized conformational epitope that requires both amino and carboxy terminal domains GPC3. HN3 inhibited proliferation GPC3-positive cells exhibited significant inhibition xenograft...

10.1073/pnas.1217868110 article EN Proceedings of the National Academy of Sciences 2013-03-05

Wnt signaling is important for cancer pathogenesis and often up-regulated in hepatocellular carcinoma (HCC). Heparan sulfate proteoglycans (HSPGs) function as coreceptors or modulators of activation. Glypican-3 (GPC3) an HSPG that highly expressed HCC, where it can attract proteins to the cell surface promote proliferation. Thus, GPC3 has emerged a candidate therapeutic target liver cancer. While monoclonal antibodies are currently being evaluated preclinical clinical studies, none have...

10.1002/hep.26996 article EN Hepatology 2014-01-06

Glypican-3 is a cell surface glycoprotein that associates with Wnt in liver cancer. We develop two antibodies targeting glypican-3, HN3 and YP7. The first antibody recognizes functional epitope inhibits signalling, whereas the second C-terminal but does not inhibit signalling. Both are fused to fragment of Pseudomonas exotoxin A (PE38) create immunotoxins. Interestingly, immunotoxin based on (HN3-PE38) has superior antitumor activity as compared YP7 (YP7-PE38) both vitro vivo. Intravenous...

10.1038/ncomms7536 article EN cc-by-nc-nd Nature Communications 2015-03-11

Wnt signaling is one of the key regulators hepatocellular carcinoma (HCC) tumor progression. In addition to classical receptor frizzled (FZD), various coreceptors including heparan sulfate proteoglycans (HSPGs) are involved in activation. Glypican‐3 (GPC3) an HSPG that overexpressed HCC and functions as a coreceptor modulates cell proliferation. These features make GPC3 attractive target for liver cancer therapy. However, precise interaction how GPC3, Wnt, FZD cooperate with each other...

10.1002/hep.30646 article EN Hepatology 2019-04-09

ABSTRACT Background Shark new antigen receptor variable domain (VNAR) antibodies can bind restricted epitopes that may be inaccessible to conventional antibodies. Methods Here, we developed a library construction method based on polymerase chain reaction (PCR)-Extension Assembly and Self-Ligation (named “EASeL”) construct large VNAR antibody with size of 1.2 × 1010 from six naïve adult nurse sharks (Ginglymostoma cirratum). Results The next-generation sequencing analysis 1.19 million...

10.1093/abt/tby011 article EN cc-by-nc Antibody Therapeutics 2018-11-07

Glypican-3 (GPC3) represents an attractive target for hepatocellular carcinoma (HCC) therapy because it is highly expressed in HCC but not adult normal tissue. Recently, high affinity anti-GPC3 antibodies have been developed; however, full may penetrate evenly into tumor parenchyma, reducing their effectiveness. In this study, we compared a whole IgG antibody, YP7, with human heavy chain HN3, regard to relative therapeutic effects. Both YP7 and HN3 bound GPC3-positive A431/G1 cells were...

10.1021/acs.molpharmaceut.5b00132 article EN Molecular Pharmaceutics 2015-05-08

Background Small cell lung cancer (SCLC) accounts for 15% of cancers, and the primary treatment this malignancy is chemotherapy radiotherapy. Delta-like 3 (DLL3) an attractive target SCLC immunotherapy since its expression highly restricted to with a neglectable appearance on normal adult tissues. In current study, we aimed explore efficacy DLL3-targeted via engagement T cell. Methods As proof concept, constructed bispecific antibody chimeric antigen receptor (CAR)-modified cells. vitro in...

10.1136/jitc-2020-000785 article EN cc-by-nc Journal for ImmunoTherapy of Cancer 2020-06-01

Abstract Consumption of dietary fiber and anthocyanin has been linked to a lower incidence colorectal cancer (CRC). This study scrutinizes the potential antitumorigenic attributes black rice diet (BRD), abundantly rich in anthocyanin. Our results demonstrate notable effects mice on BRD, indicated by reduction both size number intestinal tumors consequent extension life span, compared control diet‐fed counterparts. Furthermore, fecal transplants from BRD‐fed germ‐free led decrease colonic...

10.1002/imt2.165 article EN cc-by iMeta 2024-01-15

Chimeric antigen receptor (CAR)-modified T cell therapy has achieved remarkable efficacy in treating hematological malignancies, but it confronts many challenges solid tumors, such as the immunosuppressive microenvironment of tumors. These factors reduce antitumor activity CAR-T cells clinical trials. Therefore, we used immunocytokine interleukin-12 (IL-12) to enhance therapy. In this study, engineered CAR-IL12R54 that targeted mesothelin (MSLN) and secreted a single-chain IL-12 fused scFv...

10.1016/j.phrs.2024.107186 article EN cc-by-nc-nd Pharmacological Research 2024-04-17

Current pancreatic cancer immunotherapy focused on alphabeta (αβ) T cells, either through CD3-engaged bispecific antibodies or CAR-T. Despite their promise, dose-limited toxicity (DLT) remains a challenge in clinical practice. In light of these concerns, there is growing interest exploring alternative cell types, natural killer (NKT) cells and gammadelta (γδ) that possess the capacity to lyse tumors while potentially offering safer therapeutic profile with fewer side effects. These present...

10.3389/fimmu.2025.1524899 article EN cc-by Frontiers in Immunology 2025-02-10

Background While the role of specific nutrients in cancer is established, associations between comprehensive dietary nutrient intake and presence remain underexplored. This cross-sectional study investigates global profiles relation to solid blood cancers. Methods A total 42,732 mobile adults from National Health Nutrition Examination Survey (NHANES, 2001–2023) were enrolled this study. The potential intakes 34 4 common trace components with investigated by weighted logistic regression...

10.3389/fnut.2025.1551822 article EN cc-by Frontiers in Nutrition 2025-04-01

Background: Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the two most common primary liver cancers, yet there have been no significant advances in effective therapeutics.Mesothelin has reported as a new therapeutic target various types of cancer.Here, we investigated expression mesothelin cancer its potential role novel for immunotherapy.Methods: HCC CCA specimens were examined by immunohistochemistry expression.Protein was assessed immunoblotting flow cytometry.The SS1P...

10.7150/jca.1.141 article EN cc-by-nc Journal of Cancer 2010-01-01

Mesothelin is a glycosylphosphatidylinositol-anchored glycoprotein that highly expressed on the cell surface of mesothelioma, ovarian cancer and other malignant tumors. The interaction between mesothelin CA125 (also called MUC16) may facilitate implantation metastasis tumors in peritoneal cavity. A desirable therapeutic agent involves finding fully human monoclonal antibody (mAb) binds to or inhibits their interaction. Here, we report identification novel mAb mesothelin. HN1, single-chain Fv...

10.1002/ijc.25557 article EN International Journal of Cancer 2010-07-15

Monoclonal antibodies against mesothelin are being evaluated for the treatment of mesothelioma and multiple forms cancers, show great promise clinical development solid cancers. Antibodies have been shown to act via immunotoxin-based inhibition tumor growth induction antibody-dependent cell-mediated cytotoxicity (ADCC). However, complement-dependent (CDC), considered an important additional mechanism therapeutic tumors, is inactive such antibodies. Here, we used phage display antibody...

10.1158/1535-7163.mct-12-0731 article EN cc-by Molecular Cancer Therapeutics 2013-02-01

Glypican-3 (GPC3) is overexpressed in hepatocellular carcinoma (HCC). We constructed a recombinant immunotoxin, HN3-mPE24, which contains truncated form of Pseudomonas exotoxin A. The toxin portion lacks most domain II and has seven point mutations III to remove the B-cell epitopes thought be responsible for causing off-target side effects immunogenicity. also fused bivalent HN3 mPE24. tested these two molecules GPC3 binding cytotoxicity HCC cell models. KD values HN3-mPE24 HN3-HN3-mPE24...

10.18632/oncotarget.10592 article EN Oncotarget 2016-07-13

Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported transmembrane protein (FAT1) new interacting protein. The binding region on FAT1 was initially mapped the C-terminal (Q14517, residues 3662-4181), which covered putative receptor tyrosine phosphatase...

10.1038/s41598-020-79524-3 article EN cc-by Scientific Reports 2021-01-08

Background Tumor microenvironments present significant barriers to penetration by antibodies and immunoconjugates. microenvironments, however, are difficult study in vitro. Cells cultured as monolayers exhibit less resistance therapy than those grown vivo an alternative research model more representative of the tumor is desirable. SS1P immunotoxin composed Fv portion a mesothelin-specific antibody fused bacterial toxin that presently undergoing clinical trials mesothelioma....

10.1371/journal.pone.0014640 article EN cc-by PLoS ONE 2011-01-31

Choline participates in three major metabolic pathways: oxidation, phosphorylation, and acetylation. Through choline is converted to betaine contributes methyl metabolism epigenetic regulation. phospholipid metabolism, serves as the precursor of phosphocholine, phosphatidylcholine, glycerophosphocholine, other essential compounds, thereby modulating lipid transport. acetylation, transformed into acetylcholine cholinergic neurons, playing a vital role neurotransmission. Moreover, gut...

10.31083/j.fbl2905182 article EN cc-by Frontiers in Bioscience-Landmark 2024-05-11

Cytopathology, crucial in disease diagnosis, commonly uses microscopic slides to scrutinize cellular abnormalities. However, processing high volumes of samples often results numerous negative diagnoses, consuming significant time and resources healthcare. To address this challenge, a surface acoustic wave-enhanced multi-view acoustofluidic rotation cytometry (MARC) technique is developed for pre-cytopathological screening. MARC enhances morphology analysis through comprehensive multi-angle...

10.1002/advs.202403574 article EN cc-by Advanced Science 2024-08-13

A single G-quadruplex forming sequence from the human telomere can adopt six distinct topologies that are inter-convertible under physiological conditions. This presents challenges to design ligands show selectivity and specificity towards a particular conformation. Additional complexity is introduced in differentiating multimeric G-quadruplexes over monomeric species, which would be able form single-stranded 3' ends of telomeres. few have been reported bind dimeric quadruplexes, but their...

10.1093/nar/gkaa870 article EN cc-by Nucleic Acids Research 2020-10-14

Abstract SARS‐CoV‐2 is the etiological agent of COVID‐19 pandemic. Antibody‐based therapeutics targeting spike protein, specifically S1 subunit or receptor binding domain (RBD) SARS‐CoV‐2, have gained attention due to their clinical efficacy in treating patients diagnosed with COVID‐19. An alternative conventional antibody use shark new antigen variable (V NAR ) antibodies. V s are small (<15 kDa) and can reach deep into pockets grooves target antigen. Here, we isolated 53 that bind S2 by...

10.1096/fj.202202099rr article EN cc-by The FASEB Journal 2023-05-16
Coming Soon ...